Sekisui House (OTCMKTS:SKHSY – Get Free Report) and SSGI (OTCMKTS:VICP – Get Free Report) are both construction companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and profitability.
Earnings and Valuation
This table compares Sekisui House and SSGI”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Sekisui House | $26.67 billion | 0.55 | $1.44 billion | $2.03 | 10.99 |
SSGI | N/A | N/A | -$1.18 million | ($0.04) | -44.25 |
Volatility and Risk
Sekisui House has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, SSGI has a beta of -4.58, meaning that its share price is 558% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings for Sekisui House and SSGI, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Sekisui House | 0 | 1 | 0 | 0 | 2.00 |
SSGI | 0 | 0 | 0 | 0 | 0.00 |
Profitability
This table compares Sekisui House and SSGI’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Sekisui House | 4.78% | 9.88% | 4.10% |
SSGI | N/A | N/A | N/A |
Insider & Institutional Ownership
0.0% of Sekisui House shares are held by institutional investors. 6.0% of SSGI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Sekisui House beats SSGI on 10 of the 11 factors compared between the two stocks.
About Sekisui House
Sekisui House, Ltd. designs, constructs, and contracts built-to-order detached houses in Japan and internationally. The company operates through Custom Detached Houses, Rental Housing, Architectural/Civil Engineering, Remodeling, Real Estate Management Fees, Houses For Sale, Condominiums, Urban Redevelopment, and Overseas segments. It also engages in contracting of design and construction of custom detached houses, rental housing, office building, commercial buildings, and other properties; construction of reinforced concrete rental housing and commercial buildings; contracting of design and construction of civil engineering works; remodeling and renovation of houses; subleasing, management, operation, and brokerage of real estate; sale of houses and residential land; and sales of condominiums. Sekisui House, Ltd. was incorporated in 1929 and is headquartered in Osaka, Japan.
About SSGI
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.
Receive News & Ratings for Sekisui House Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sekisui House and related companies with MarketBeat.com's FREE daily email newsletter.